One-Year Patient Reported Outcomes and Lymphedema in Node-Positive Breast Cancer in the Prospective Multicenter Neosenti-Turk/MF-18-03 study: Is there any benefit of Targeted Axillary Dissection over Sentinel Lymph Node Biopsy?
26th Annual Meeting of the American-Society-of-Breast-Surgeons (ASBrS), Las vegas, United States Of America, 30 April 2025, vol.32, pp.579-580, (Summary Text)